April 4, 2024 02:22 PM EDT
Pharma
Law

Sanofi ends al­most all state per­son­al in­jury law­suits over Zan­tac with undis­closed set­tle­ment

Katherine Lewin

News Reporter

Sanofi has agreed to set­tle about 4,000 cas­es in the sprawl­ing lit­i­ga­tion over the heart­burn drug Zan­tac and claims that it con­tained a car­cino­gen that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times